Advanced Search

Refine my results

Document type

Institution

Specific Collection

Language

Author

Domain

Keyword

Sorted by: Date of deposit
2 results 1
Postprint
Consortium of Swiss Academic Libraries

45PCost-effectiveness analysis of VEGF-A testing to predict response to bevacizumab (BEV) as a component of neo-adjuvant therapy of early HER-2 negative breast cancer

Blank, P.R. ; Loibl, S. ; Linderholm, B.K. ; Caramuta, S. ; Nekljudova, V. ; Szucs, T.D. ; Van Stiphout, J. ; Ademi, Z. ; von Minckwitz, G. ; Schwenkglenks, M.

In: Annals of Oncology, 2015, vol. 26, p. iii16-iii17

Postprint
Consortium of Swiss Academic Libraries

Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)†

Gerber, B. ; Loibl, S. ; Eidtmann, H. ; Rezai, M. ; Fasching, P. A. ; Tesch, H. ; Eggemann, H. ; Schrader, I. ; Kittel, K. ; Hanusch, C. ; Kreienberg, R. ; Solbach, C. ; Jackisch, C. ; Kunz, G. ; Blohmer, J. U. ; Huober, J. ; Hauschild, M. ; Nekljudova, V. ; Untch, M. ; von Minckwitz, G.

In: Annals of Oncology, 2013, vol. 24, no. 12, p. 2978-2984

2 results 1